Clinical Trial Update: Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intepirdine (RVT-101) for dementia with Lewy bodies has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia with Lewy Bodies

Drugs mentioned

• Intepirdine (invoked as intepirdine)

Snippet

Sponsor: Axovant Sciences Ltd. | Conditions: Dementia With Lewy Bodies | Phase 2 | Status: COMPLETED | Results posted: 2019-04-26